- Country: Russia
- Summary: Supply of Medicinal Products for Medical Use (Inn Alpha-Tocopherol Acetate Retinol, Venlafaxine, Hydroxychloroquine, Dexpanthenol, Magnesium Sulfate, Boric...
- RUT Ref No: 99543221
- Deadline: 05 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 397301.00
- Notice Type: Tender
- Document Ref. No.: 0372200008624000054
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of medicines for medical use (INN Alpha-tocopherol acetate Retinol, Venlafaxine, Hydroxychloroquine, Dexpanthenol, Magnesium sulfate, Boric acid Resorcinol Phenol Fuchsin, Fusidic acid) for the needs of St. Petersburg State Budgetary Institution "City Dermatovenerological
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Medicinal Products for Medical Use (Inn Alpha-Tocopherol Acetate Retinol, Venlafaxine, Hydroxychloroquine, Dexpanthenol, Magnesium Sulfate, Boric... - Russia Tender
The ST. PETERSBURG STATE BUDGETARY HEALTH INSTITUTION "CITY VENEROLOGICAL CLINICAL, a Government sector organization in Russia, has announced a new tender for Supply of Medicinal Products for Medical Use (Inn Alpha-Tocopherol Acetate Retinol, Venlafaxine, Hydroxychloroquine, Dexpanthenol, Magnesium Sulfate, Boric.... This tender is published on RussiaTenders under RUT Ref No: 99543221 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-05.
The estimated tender value is RUB 397301.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
